TP-472
CAS No. 2079895-62-6
TP-472( TP472 )
Catalog No. M13237 CAS No. 2079895-62-6
TP-472 is a novel BRD9/7 chemical probe that has excellent potency (BRD9 KD=33nM; BRD7 KD=340 nM by ITC).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTP-472
-
NoteResearch use only, not for human use.
-
Brief DescriptionTP-472 is a novel BRD9/7 chemical probe that has excellent potency (BRD9 KD=33nM; BRD7 KD=340 nM by ITC).
-
DescriptionTP-472 is a novel BRD9/7 chemical probe that has excellent potency (BRD9 KD=33nM; BRD7 KD=340 nM by ITC), >30 fold selectivity over all other bromodomain family members except BRD7 and is cell active (EC50 320 nM in a BRD9 NanoBRET assay); has a good PK profile and is suitable for in vivo applications.
-
In VitroTP-472 (1 μM, 3 μM; 24-216 hours) yields concentration-dependent growth defects in ESCs.TP-472 (0.1-10 μM; 24 h) effectively inhibits the growth of both the BRAF mutant melanoma cell lines at 5 and 10 μM concentrations.TP-472 (for 2 weeks) also strongly inhibits the long-term survival of multiple melanoma cell lines (M14, SKMEL-28, A375, and A2058) at concentrations of 5 and 10 μM.TP-472 (5-10 μM; 24 h) treatment downregulates genes encoding various extracellular matrix (ECM) proteins, including integrins, collagens, and fibronectins in A375 cells.TP-472 (0.1-10 μM; 24 h) results in the upregulation of pro-apoptotic genes (BAX, MDM2, CDKN1A) in A375 cells.Cell Viability Assay Cell Line:Embryonic stem cells Concentration:1 μM, 3 μM Incubation Time:24 hours, 72 hours, 120 hours, 168 hours, 216 hours Result:Yields concentration-dependent growth defects in ESCs.Cell Proliferation Assay Cell Line:M14 and SKMEL-28 cells Concentration:0.1 μM, 0.5 μM, 1 μM, 2 μM, 5 μM, 10 μM Incubation Time:24 h Result:Effectively inhibited the growth of both the BRAF mutant melanoma cell lines.Western Blot Analysis Cell Line:A375 cells Concentration:10 μM Incubation Time:24 h Result:Resulted in the upregulation of pro-apoptotic genes.
-
In VivoTP-472 (20 mg/kg; i.p.; three times a week; for 5 weeks) significantly inhibits the subcutaneous tumor growth in melanoma xenograft mouse model. Animal Model:NSG mice injected with A375-MA2 cells (male five- to six-week-old) Dosage:20 mg/kg Administration:i.p.; three times a week; for 5 weeks Result:Significantly inhibited the subcutaneous tumor growth in melanoma xenograft mouse model.
-
SynonymsTP472
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2079895-62-6
-
Formula Weight333.391
-
Molecular FormulaC20H19N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (299.96 mM)
-
SMILESCC1=C(C=C(C=C1)C(=O)NC2CC2)C3=C4N=CC=CN4C(=C3)C(=O)C
-
Chemical Name3-(6-acetylpyrrolo[1,2-a]pyrimidin-8-yl)-N-cyclopropyl-4-methylbenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pérez-Salvia M, et al. Epigenetics. 2017 May 4;12(5):323-339.
molnova catalog
related products
-
Mivebresib
Mivebresib (ABBV-075) is a potent and orally available BET bromodomain inhibitor with Ki of 1.0, 12.2, 1.5, and 2.2 nM for BRD2, BRD3, BRD4 and BRDT, respectively.
-
BRPF1B TRIM24-IN-34
BRPF1B TRIM24-IN-34 is a selective BRPF1B/TRIM24 dual inhibitor that binds with KD of 137 and 222 nM, respectively.
-
BETi-211
A novel potent small-molecule BET bromodomain (BRD) inhibitor that binds to BET proteins with Ki values of <1 nM.
Cart
sales@molnova.com